STOCK TITAN

Altimmune CFO receives 18,750 shares on conversion

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

At Altimmune, Inc. (ALT), Chief Financial Officer Gregory L. Weaver converted 18,750 restricted stock units into 18,750 common shares on November 11, 2026. He surrendered 5,672 shares solely to cover taxes associated with RSU vesting; those shares were reported at $1.93 per share. Weaver's reported post-transaction RSU balance was 37,500. No Rule 10b5-1 plan is reported.

Insider WEAVER GREGORY L
Role Chief Financial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F3 18,750 $0.00 $0.00
Exercise Common Stock, par value $0.0001 F1 18,750 $0.00 $0.00
Tax Withholding Common Stock, par value $0.0001 F2 5,672 $1.93 $11K
Holdings After Transaction: Restricted Stock Units — 37,500 units (Direct); Common Stock, par value $0.0001 — 63,005 shares (Direct)
Holdings Before and After: Restricted Stock Units, 56,250 to 37,500 units (Direct); Common Stock, par value $0.0001, 49,927 to 63,005 shares (Direct)
Footnotes (3)
  1. F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
  2. F2. Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
  3. F3. The RSUs become vested over four (4) years with 25% of the shares vesting on November 11, 2025, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
Restricted stock units converted 18,750 restricted stock units Converted into common shares on November 11, 2026
Common shares acquired 18,750 shares Received upon conversion on November 11, 2026
Shares surrendered for taxes 5,672 shares Surrendered solely to cover taxes associated with RSU vesting
Reported per-share price $1.93 per share For the shares surrendered to cover taxes
Post-transaction RSU balance 37,500 restricted stock units Reported balance following the transaction
Restricted Stock Unit financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"represents a contingent right to receive one share of Common Stock"
vesting transaction financial
"Vesting transaction: Shares surrendered to the Issuer solely to cover taxes"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALT shares did CFO Gregory L. Weaver receive and surrender?

On November 11, 2026, Gregory L. Weaver converted 18,750 restricted stock units into 18,750 common shares and surrendered 5,672 shares solely to cover taxes associated with RSU vesting. The surrendered shares were reported at $1.93 per share, and his post-transaction RSU balance was 37,500. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEAVER GREGORY L

(Last)(First)(Middle)
350 MOUNT KEMBLE AVENUE
SUITE 1001

(Street)
MORRISTOWN NEW JERSEY 07960

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Altimmune, Inc. [ ALT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.000111/11/2026M18,750A$0(1)68,677D
Common Stock, par value $0.000111/11/2026F(2)5,672D$1.9363,005D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)11/11/2026M18,750 (3) (3)Common Stock, par value $0.000118,750$037,500D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
2. Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs.
3. The RSUs become vested over four (4) years with 25% of the shares vesting on November 11, 2025, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.
/s/ Gregory Weaver11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading